FDAMA Pediatric Exclusivity Expansion Could Be Considered By FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA may be willing to discuss new incentives for manufacturers to conduct pediatric studies on products not covered under the FDA Modernization Act's pediatric exclusivity rule, FDA Commissioner Jane Henney, MD, said at a Senate Health, Education, Labor & Pensions Committee hearing on FDAMA Oct. 21.You may also be interested in...
People In Brief
Perrigo promotes in pricing, planning
In Brief
Combe sells most of its OTC brands
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports